All Stories

  1. Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales

    Article • Gut Microbes, August 2018, Taylor & Francis

    Dr Christian R Kahlert, Dr Paul G Higgins, Anastasia Tsakmaklis

  2. Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumannii: TABLE 1

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Dr Paul G Higgins

  3. The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr Paul G Higgins

  4. Amino acid alterations in fibronectin binding protein A (FnBPA) and bacterial genotype are associated with cardiac device related infection in Staphylococcus aureus bacteraemia

    Article • Journal of Infection, February 2015, Elsevier

    Dr Paul G Higgins

  5. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, January 2015, Society for General Microbiology

    Dr Paul G Higgins

  6. Detection of pan drug-resistant Acinetobacter baumannii in Germany

    Article • Journal of Antimicrobial Chemotherapy, May 2014, Oxford University Press (OUP)

    Dr Paul G Higgins

  7. Worldwide dissemination of acquired carbapenem-hydrolysing class D β-lactamases in Acinetobacter spp. other than Acinetobacter baumannii

    Article • International Journal of Antimicrobial Agents, April 2014, Elsevier

    Dr Paul G Higgins

  8. Characterization of blaOXA-143 Variants in Acinetobacter baumannii and Acinetobacter pittii

    Article • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals

    Dr Paul G Higgins

  9. Molecular epidemiology characterization of OXA-23 carbapenemase-producing Acinetobacter baumannii isolated from 8 Brazilian hospitals using repetitive sequence–based PCR

    Article • Diagnostic Microbiology and Infectious Disease, December 2013, Elsevier

    Dr Paul G Higgins

  10. Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acinetobacter spp.

    Article • Journal of Antimicrobial Chemotherapy, November 2013, Oxford University Press (OUP)

    Dr Paul G Higgins

  11. Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolate

    Article • Journal of Antimicrobial Chemotherapy, August 2013, Oxford University Press (OUP)

    Dr Paul G Higgins

  12. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)

    Article • Clinical Microbiology and Infection, August 2013, Elsevier

    Dr Paul G Higgins

  13. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii

    Article • International Journal of Medical Microbiology, March 2013, Elsevier

    Dr Paul G Higgins

  14. OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, February 2013, ASM Journals

    Dr Paul G Higgins

  15. Identification of a novel insertion sequence element associated with carbapenem resistance and the development of fluoroquinolone resistance in Acinetobacter radioresistens

    Article • Journal of Antimicrobial Chemotherapy, November 2012, Oxford University Press (OUP)

    Dr Paul G Higgins

  16. Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane

    Article • International Journal of Medical Microbiology, July 2012, Elsevier

    Dr Paul G Higgins

  17. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran

    Article • International Journal of Antimicrobial Agents, June 2012, Elsevier

    Dr Paul G Higgins

  18. Association between β-Lactamase-EncodingblaOXA-51Variants and DiversiLab Rep-PCR-Based Typing of Acinetobacter baumannii Isolates

    Article • Journal of Clinical Microbiology, March 2012, ASM Journals

    Dr Paul G Higgins

  19. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States

    Article • Journal of Infection, March 2012, Elsevier

    Dr Paul G Higgins

  20. In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

    Article • Journal of Antimicrobial Chemotherapy, January 2012, Oxford University Press (OUP)

    Dr Paul G Higgins

  21. Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital

    Article • International Journal of Infectious Diseases, October 2011, Elsevier

    Dr Paul G Higgins

  22. Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolates

    Article • Journal of Medical Microbiology, September 2011, Society for General Microbiology

    Dr Paul G Higgins

  23. gyrBMultiplex PCR To Differentiate betweenAcinetobacter calcoaceticusandAcinetobacterGenomic Species 3

    Article • Journal of Clinical Microbiology, September 2010, ASM Journals

    Dr Paul G Higgins

  24. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii

    Article • International Journal of Antimicrobial Agents, September 2010, Elsevier

    Dr Paul G Higgins

  25. Global spread of carbapenem-resistant Acinetobacter baumannii

    Article • Journal of Antimicrobial Chemotherapy, April 2010, Oxford University Press (OUP)

    Dr Paul G Higgins

  26. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

    Article • International Journal of Antimicrobial Agents, March 2010, Elsevier

    Dr Paul G Higgins

  27. Activity of the Investigational Fluoroquinolone Finafloxacin against Ciprofloxacin-Sensitive and -Resistant Acinetobacter baumannii Isolates

    Article • Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals

    Dr Paul G Higgins

  28. Global spread of carbapenem-resistant Acinetobacter baumannii

    Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

    Dr Paul G Higgins

  29. OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, September 2009, ASM Journals

    Dr Paul G Higgins

  30. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital

    Article • Clinical Microbiology and Infection, July 2008, Elsevier

    Dr Paul G Higgins

  31. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme

    Article • Clinical Microbiology and Infection, July 2008, Elsevier

    Dr Paul G Higgins

  32. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU

    Article • Clinical Microbiology and Infection, December 2007, Elsevier

    Dr Paul G Higgins

  33. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

    Article • Journal of Antimicrobial Chemotherapy, August 2004, Oxford University Press (OUP)

    Dr Paul G Higgins

  34. Fluoroquinolones: Structure and Target Sites

    Article • Current Drug Targets, February 2003, Bentham Science Publishers

    Dr Paul G Higgins

  35. Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa

    Article • Journal of Antimicrobial Chemotherapy, August 2002, Oxford University Press (OUP)

    Dr Paul G Higgins

  36. Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro

    Article • Journal of Antimicrobial Chemotherapy, April 2000, Oxford University Press (OUP)

    Dr Paul G Higgins, Dr Ken Coleman

  37. Variation in the Cell Surface Proteins of Clostridium difficile

    Article • Anaerobe, June 1999, Elsevier

    Dr Paul G Higgins